
IBB is a multidisciplinary research institute dedicated to the study of the molecular and cellular mechanisms underlying physiological and pathological processes through experimental, computational, and technological approaches. From the development and characterization of biomolecules to biomedical imaging and digital health solutions, IBB promotes scientific knowledge and develops innovative tools for diagnosis and therapy.
Learn more about our Institute
Advancing knowledge through discovery
State-of-the-art resources and services
Public engagement and science communication
Bringing research into innovation
Job and training opportunities
The PreMI Center is part of the Italian node of Euro-BioImaging, the European research infrastructure for biological and biomedical imaging.
VISIT THE PORTAL ↗
The PreMI Center is the preclinical imaging infrastructure of IBB–CNR in Naples and is part of the Multi-Modal Molecular imaging (MMMI) Italian node of Euro-BioImaging. The infrastructure provides state-of-the-art instruments and expertise in structural, functional, and molecular imaging, supporting biomedical and translational research.





The SIM Lab infrastructure makes the IBB a leading center for the molecular study of biological processes involved in the onset and progression of human diseases. The services offered include the production of proteins and peptides of biological and biotechnological interest, their biophysical, biochemical, and structural characterization, as well as the analysis of interactions with specific molecular targets. Thanks to multidisciplinary expertise and advanced instrumentation, the infrastructure supports basic and translational research, applied in the life sciences and biomedicine sectors.














The Radiation Protection and Medical Physics Service is an internal technical and scientific unit of the IBB-CNR Institute. It is organized into three specialized divisions, staffed by qualified personnel holding the professional competencies and legal certifications required to manage the operational activities related to Radiation Protection and Medical Physics, both within the Institute and through external collaborations.
The Head of the Service is Dr. Giorgio Punzo.






















The IBB operates advanced research infrastructures dedicated to the structural and functional characterization of biomolecules (SIM Lab) and preclinical imaging (PreMI Center). These infrastructures provide the national and international scientific community with high-tech instruments, specialized expertise, and services to support research and innovation activities. The IBB also has a Radiation Protection Service that ensures the safe and regulatory-compliant management of research activities involving the use of radioactive sources and radionuclides, ensuring compliance with safety standards for personnel, users, and the environment.
IBB research is divided into seven macro-areas dedicated to understanding biological systems and developing innovative health solutions, from basic research to translational applications.
Research in the E-health and open data focuses on the development of digital solutions for remote patient monitoring and for the management, integration, and sharing of health data, within the broader scientific framework of One Digital Health, which promotes a unified approach to the digital interpretation of relationships across the human, animal, and environmental domains.
Research activities focus on the advanced modeling of clinical processes, the design of interoperable digital architectures based on Cloud, Edge Computing, and Internet of Things technologies, and the development of telemedicine platforms integrated with mobile applications, wearable devices, and smart devices. The aim is to integrate information from heterogeneous devices, applications, and healthcare systems through the continuous collection of physiological, behavioral, and clinical data.
Data Stewardship activities, conducted according to the principles of Open Science and FAIR (Findability, Accessibility, Interoperability, and Reusability), include the management, annotation, standardization, and sharing of biomedical datasets, with particular attention to clinical and preclinical imaging data and to the use of certified standards and repositories.
The main objective is to foster the development of a digital ecosystem in which patients, devices, and data can be integrated in an interoperable, reliable, and reusable manner, supporting biomedical research and new models of personalized care.
IBB also promotes research results through patents and spin-offs, fostering the transfer of knowledge and technologies towards concrete applications. These activities enable the development of collaborations with companies and external partners, supporting the development of innovative solutions in the biomedical, biotechnological, and digital fields.
List of patents and technologies developed by the Institute's staff.
2024 |
Highly stable antigen-presenting fusion proteins and uses thereof as vaccine components for the therapy and/or prophylaxis of pathogenic bacteria►PCT/EP2024/081833 - WO2025099310 A1Antigeni cross-protettivi contro batteri Gram-positivi, con potenziali applicazioni nello sviluppo di strategie preventive e vaccinali. Inventors: Rita Berisio, Flavia Squeglia, Johannes Huebner. |
2024 |
Use of exahusted coffee grounds for the production of the phytocompounds ursolic acid and chlorogenic acid from apple vegetable calluses►IT202400004489 A1Metodo per l’impiego di fondi di caffè esausti in colture cellulari vegetali, finalizzato alla produzione di composti bioattivi di interesse biotecnologico. Inventors: Antonio Di Loria, Vincenzo D’Amelia, Carmen Laezza, Maria Manuela Rigano, Simona Maria Monti. |
2023 |
Highly stable antigen-presenting fusion proteins and uses thereof as vaccine components for the therapy and/or prophylaxis of pathogenic bacteria►PCT/EP2024/081833 - WO2025099310 A1Nuovo antigene contro batteri patogeni Gram-positivi, con possibili applicazioni nello sviluppo di approcci immunologici. Inventors: Rita Berisio, Flavia Squeglia, Johannes Hübner, Felipe Romero-Saavedra. |
2023 |
Apple peel calluses and their cultivation for the production of phytocompounds phlorizin and ursolic acid►IT202300011208 A1Tecnologia basata su colture cellulari vegetali ottenute da buccia di mela per la produzione controllata di fitocomposti di interesse nutraceutico e biotecnologico. Inventors: Maria Manuela Rigano, Antonio Di Loria, Vincenzo D’Amelia, Simona Maria Monti, Carmen Laezza, Ettore Novellino, Giancarlo Tenore. |
2021 |
Method of gene editing to increase the anthocyanin content in potato cells►IT202100000785 A1Metodo di gene editing applicato a cellule di patata per incrementare il contenuto di antocianine, composti di interesse per le loro proprietà antiossidanti e nutrizionali. Inventors: Vincenzo D’Amelia, Domenico Carputo, Annalisa Staiti, Riccardo Aversano, Maria Manuela Rigano, Antonio di Loria, Simona Maria Monti. |
2021 |
Binding peptides and uses thereof►US2022015501 WL’uso del fattore di induzione dell’apoptosi (AIF) e di peptidi leganti la peptidil-prolil cis-trans isomerasi (PPIA) per prevenire la morte delle cellule miocardiche e/o la morte cardiaca improvvisa. Inventors: Stephen P. Chelko, Nazareno Paolocci, Daniel P. Judge, Gizem Keceli, Peter Andersen, Nuria Amat, Nunzianna Doti, Menotti Ruvo, Alessandra Monti. |
2018 |
Novel Peptides and Peptidomimetics as Potent Targeted Agents►102018000010511Peptidi in grado di inibire l’azione dei fibroblasti associati al tumore (CAF), contrastando la migrazione e l’invasività delle cellule tumorali e infiammatorie. Inventors: Maria Patrizia Stoppelli, Paola Franco, Francesca Iommelli, Stefania Belli, Alfonso Carotenuto, Paolo Grieco, Ettore Novellino. |
2014 |
Anti-NODAL antibodies and methods of using same►15849199.3 - US2016130335 A1Anticorpi monoclonali anti-Nodal e il loro impiego in ambito diagnostico e terapeutico per patologie associate all’overespressione della proteina Nodal. Inventors: Menotti Ruvo, Annamaria Sandomenico, Antonio Leonardi, Luca Sanguigno, Mary J. C. Hendrix, Elisabeth A. Seftor, Richard E. B. Seftor, Luigi Strizzi, Zhila Khalkhali-Ellis. |
2011 |
Method of Diagnosis and Prognosis►49161839 - US2014128330 A1Metodo diagnostico e prognostico per il mieloma multiplo basato sulla misurazione dell’espressione di Gadd45β in cellule CD138⁺, utile anche per guidare scelte terapeutiche mirate. Inventors: Guido Franzoso, Antonio Palumbo, Alberto Rocci, Menotti Ruvo, Laura Tornatore. |


IBB participates in various doctoral programs in collaboration with leading Italian and international universities, contributing to the training of young researchers.
Thesis title: Targeting Kras isoforms in cancer
Tutor: Alfonso De Simone, Alessia Ruggiero
Università degli Studi di Napoli "Federico II"
Thesis title: Galectins: structural aspects, functional mechanisms and potential therapeutic approaches based on selective inhibitors
Tutor: Ilaria Baglivo, Emilia Pedone, Sonia Di Gaetano
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Targeting the Functional Link Between CA IX and Ferroptosis for Innovative Cancer Therapeutics
Tutor: Giuseppina De Simone, Vincenzo Alterio, Anna Di Fiore
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Structure-based targeting of phosphoetanolamine transferases to contrast colistin resistance
Tutor: Rita Berisio, Maria Romano, Angela Chambery
Università degli Studi di Siena
Thesis title: Antibody-Antimicrobial conjugates (AAC) to combat infectious diseases
Tutor: Annamaria Sandomenico, Angela Chambery
Università degli Studi di Siena | Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: BIO-CATCH: Biotecnologie innovative per la cattura sostenibile della CO2 tramite microalghe
Tutor: Simona Maria Monti, Daria Maria Monti
Università degli Studi di Napoli Federico II
Thesis title: Novel biomolecules modulating viral RNA capping machinery in CoV infection
Tutor: Gaetano Malgieri, Laura Zaccaro, Annarita Del Gatto
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Biotechnological approaches for insect population control: defining the molecular basis of sex determination in agricultural pests
Tutor: Luigi Vitagliano, Antonio Fiorentino
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Multiple Decoration of Nanoplatform for Targeted Drug Delivery
Tutor: Menotti Ruvo, Emanuela Iaccarino, Angela Chambery
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: The role of N-terminal domain of Human Prion Protein in recognition and aggregation processes
Tutor: Luigi Russo, Lucia De Rosa
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Structural and functional studies of bacterial molecular machineries as tools against antimicrobial resistance
Tutor: Rita Berisio, Valeria Napolitano, Angela Chambery
Università degli Studi di Siena
Thesis title: Purification strategies of therapeutic proteins from human plasma
Tutor: Menotti Ruvo, Angela Chambery, Alessandro Carlucci
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Application of biostimulant peptides: AI-driven solutions for a sustainable approach
Tutor: Simona Maria Monti, Alessandro Cilardo
Università degli Studi di Napoli Federico II
Thesis title: Structural and physical-chemical studies of bacterial molecular machineries as tools against antimicrobial resistance
Tutor: Pompea Del Vecchio, Rita Berisio
Università degli Studi di Napoli "Federico II"
Thesis title: Microalgae circular economy: carbon capture mediated by immobilized carbonic anyhdrases and biomass valorization
Tutor: Simona Maria Monti, Daria Maria Monti
Università degli Studi di Napoli Federico II
Thesis title: Alternative strategies against emerging pathogens through structural studies
Tutor: Rita Berisio, Flavia Squeglia
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Targeting galectins: innovative strategies for the identification and validation of selective inhibitors
Tutor: Paolo Vincenzo Pedone, Michele Saviano, Luciano Pirone
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Targeting CHCHD4 import pathway for neuroprotection
Tutor: Nunzianna Doti, Menotti Ruvo, Angela Chambery
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Prosystemin: towards a deeper understanding of its molecular role in plant defense and crop protection
Tutor: Simona Maria Monti, Rosa Rao
Università degli Studi di Napoli Federico II
Thesis title: Biocompatible polymers for human health
Tutor: Rita Berisio, Alessia Ruggiero
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: The multifaceted Galectin-3 protein: a step forward to the comprehension of its roles by the identification and characterization of novel inhibitors
Tutor: Paolo Vincenzo Pedone, Emilia Pedone
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Development of a Purification Protocol for Factor V zymogen from human Plasma Fractions
Tutor: Nunzianna Doti, Menotti Ruvo, Angela Chambery
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Development of new and selective (radio)metal-peptide conjugates for targeted therapy and diagnosis of high malignant cancers
Tutor: Zaccaro, Annarita Del Gatto
Università di Padova
Thesis title: Insights into Bacterial Carbonic Anhydrases as novel targets for antimicrobial therapy
Tutor: Giuseppina De Simone, Simona Maria Monti
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Structural and functional characterization of the recombinant FVII of coagulation
Tutor: Menotti Ruvo, Annamaria Sandomenico, Angela Chambery
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Structural and functional characterization of novel vaccine antigens against dangerous pathogens
Tutor: Rita Berisio
Università degli Studi della Campania "Luigi Vanvitelli"
Thesis title: Preparation of recombinant Fabs and their use as Targeting agents
Tutor: Menotti Ruvo, Annamaria Sandomenico, Luigi Vitagliano, Angela Chambery
Università degli Studi della Campania "Luigi Vanvitelli"

In addition to carrying out institutional professional and research activities, the Service also provides consultancy services to other public bodies under specific operational agreements, providing in particular the following professional figures:

Research in Bioimaging and Medical Physics focuses on the development, validation, and application of quantitative methods for the characterization of physiological and pathological processes, with the aim of supporting diagnosis, prognosis, and the assessment and monitoring of treatment response.
Research activities include:
• Development and optimization of imaging techniques, with particular emphasis on magnetic resonance imaging and nuclear medicine, together with advanced computational methods for image analysis. These include image segmentation and registration, correction of artifacts and partial volume effects, reconstruction of quantitative maps, and multimodal data integration. A dedicated research line focuses on the development of digital and physical phantoms, including anthropomorphic models produced through prototyping and 3D printing, to support the validation, standardization, and harmonization of quantitative imaging methods.
• Radiomics, advanced data analysis, and personalized computational modeling, with applications in neurology, oncology, inflammatory diseases, cardiovascular medicine, and pediatrics.
• Dosimetry and assessment of the effects of ionizing radiation in both clinical and preclinical settings. Dedicated activities address the characterization of dose measurement systems and the optimization of diagnostic imaging and radiotherapy protocols. Radiobiological and predictive models are developed by integrating dosimetric, clinical, and imaging data through advanced statistical methods, voxel- and image-based approaches, and machine learning techniques. Emphasis is placed on multicenter validation, model robustness, reproducibility, and the translation of quantitative methods and predictive models into clinical practice.
Research at IBB extends beyond the laboratory: it grows through exchange, is enriched by dialogue with society, and creates value when shared. For this reason, the Institute promotes an open, accessible, and participatory approach to science, creating opportunities for interaction between the research community and citizens, students, schools, and local communities.
IBB is part of CREO – Campania Research Outreach Network of the National Research Council (CNR), a network established to enhance and coordinate science communication and public engagement activities across the region, fostering collaboration among Institutes and developing new opportunities for participation and cultural growth.
Each year, the Institute contributes to major science communication events, offering the public opportunities to experience research first-hand and gain insight into the work of researchers and the role of science in society.
Through hands-on laboratories, guided visits, educational activities, public events, orientation programmes, and collaborations with schools, IBB promotes dialogue between research and society and encourages active and informed participation.
The goal is to make scientific knowledge increasingly accessible and to contribute to building an open, inclusive, and shared culture of research.
See more

This section contains the training, collaboration, and career opportunities offered by the Institute, aimed at students, researchers, and professionals interested in contributing to research, technological development, and project support.
IBB contributes to doctoral training through research activities, scientific supervision, and collaborations with universities and research centers.
Practical laboratory experience aimed at developing professional and transversal skills. To complete an internship at our institute, submit your request.
Direct experiences in research laboratories to learn about the scientific method and researchers' work. Requests must be submitted by the school using the application form.| Al momento non sono disponibili bandi attivi. Ti invitiamo a visitare periodicamente questa sezione per rimanere aggiornato sulle prossime opportunità. |
||
Expired Opportunities |
||
| Bando | Scadenza | |
| Borsa di Ricerca - Torino | 03/06/2026 | See more |
| Borsa di Ricerca - Napoli | 20/05/2026 | See more |
| Borsa di Ricerca - Napoli | 09/05/2026 | See more |
Compila il modulo per essere ricontattato dal nostro staff e progettare insieme il percorso più adatto alle esigenze della tua scuola.
The Clinical Research Area is a multidisciplinary environment dedicated to studying the physiological and pathological processes of the human body, with the aim of preventing illness, developing new therapeutic strategies, and enhancing diagnostic and treatment technologies.
Researchers working in this field draw on expertise from medicine, medical physics, biomedical engineering, healthcare informatics, chemistry, biochemistry, and bioinformatics, helping advance a more personalized and data-driven approach to healthcare.
Research activities span the following sub-areas:
E-health and innovative patient monitoring systems: development of telemedicine platforms integrated with mobile apps, wearable technologies and smart devices for the remote monitoring of vulnerable patients and the digital management of clinical data.
Quantitative medical imaging: development and application of methods for medical image processing and quantification, with a particular focus on neurological disorders, including the use of phantoms produced by rapid prototyping and studies of brain activation using functional MRI (fMRI).
Clinical bioimaging: use of biomedical imaging techniques to investigate chronic inflammatory, oncological, neurological, pediatric and cardiovascular diseases.
Radiation Physics and Medical Physics: development of advanced dosimetry methods, radiobiological modelling of the effects of ionizing radiation, and predictive models based on clinical and imaging data. These activities include the integration of artificial intelligence and machine learning techniques for quantitative analysis and the personalization of radiotherapy treatments.
Data repositories and open science: development of open-source tools for the management, annotation and sharing of (pre)clinical imaging datasets, promoting the adoption of FAIR principles and the use of recognized standards and certified repositories.
The In vivo Preclinical Research Area focuses on experimental studies of human pathologies through the use of mouse models with the aim of understanding the biological, physiological and pathological mechanisms, assessing the efficacy and safety of new drugs or therapies, and generating translational data that can support clinical applications in humans.
The in vivo preclinical research is based on two complementary approaches: the characterization of disease phenotypes in murine models of human disorders, and the use of preclinical imaging as a non-invasive tool to investigate pathological mechanisms and to evaluate therapeutic responses.
These approaches represent a highly advanced and strategic resource, allowing the non-invasive detection of disease biomarkers (neurological, oncological and cardiovascular), the development of imaging-based diagnostic methods, and the acquisition of anatomical, functional and dynamic data from experimental animals, including genetically modified models. Moreover, it is possible to analyze physiological and pathological processes in vivo, investigate tissue metabolism and assess early responses to novel therapeutic interventions. Longitudinal studies can be performed in the same subject, reducing inter-experimental variability and consequently limiting the number of animals required, in full accordance with the principles of the 3Rs (Replacement, Reduction and Refinement).
Within our Institute, the facility Preclinical Molecular Imaging (PreMI) Center is part of the Italian node of the Multi-sited Multi-Modal Molecular Imaging (MMMI) platform within the European Euro-BioImaging research infrastructure. The Center hosts state-of-the-art instrumentations for structural, functional and molecular imaging of small rodents and for the morpho-functional characterization of animal models of human disease, fostering close integration between in vitro biomedical research and in vivo molecular research programs. The activities of the in vivo preclinical imaging area include also the imaging laboratories of the Molecular Imaging Center at the Molecular Biotechnology Center of the University of Turin (CBM–UniTO), as well as providing access to microPET and Magnetic Resonance Imaging facilities at CEINGE – Advanced Biotechnologies in Naples.
The Cellular Biology Area focuses on the study of the fundamental mechanisms that regulate cellular function and the behaviour of their molecular components. Research activities encompass molecular oncology, 2D and 3D cell models, and the molecular mechanisms underlying human disease. Through integrated approaches combining genetics, biochemistry and bioinformatics, researchers investigate gene expression, intracellular signaling pathways, and interactions between cells and their microenvironment, with particular emphasis on the processes that drive neoplastic transformation, tumor progression and responses to therapy. Advanced methodologies are employed in the cell biology laboratories of our Institute and at the SIM facility, including high-resolution microscopy, next-generation sequencing and omics-based analyses. These approaches enable in-depth investigation of the cellular and molecular mechanisms underlying disease. The aim of Cell biology area is to understand the principles governing complex pathological processes, identify novel therapeutic targets, and develop innovative strategies for diagnosis and treatment of human diseases. By bridging basic science and biomedical applications, this area contributes to translating fundamental knowledge of cellular and molecular processes into advances in human health and biotechnology.
The Structural Biology Area investigates the three-dimensional structures of proteins, nucleic acids, and macromolecular complexes, using advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy.
Characterizing these molecules at the atomic level and exploring the relationship between their structure and function are essential for understanding the molecular mechanisms underlying physiological and pathophysiological processes. This knowledge is essential for the design and development of new drugs and novel molecular entities, with applications in the biomedical and biotechnological fields.
Our Institute is equipped with a structural biology laboratory featuring high-throughput crystallization platforms, an in-house diffractometer for crystallographic analysis, and a 500 MHz Bruker Avance NMR spectrometer, all accessible through the SIM facility.
The Structural Biology Area is also an active member of the CNR Structural Biology Network (SBN@CNR), a strategic initiative aimed at strengthening expertise and infrastructure in the field of structural biology by promoting interdisciplinary collaboration, methodological innovation, and synergies among CNR research groups active in this area.
The Molecular Biology and Biophysics Area is dedicated to investigating the mechanisms that determine the structure, function, and interactions of biological macromolecules. Research activities include the design and recombinant production of proteins and antibodies, their biophysical characterization in solution, and the analysis of biomolecular interaction (protein–protein and protein–ligand interactions: small organic molecules, peptides, nucleic acids, peptidomimetics, and bioconjugates), with the aim of understanding their roles in cellular processes in physiopathological conditions, as well as identifying new diagnostic and therapeutic targets.
Through integrated approaches in molecular biology, biochemistry, and biophysics, carried out in dedicated laboratories and at the SIM facility, biomolecules of interest are produced and characterized in terms of stability and functionality, both individually and in complexes with macromolecular partners.
Research activities combine genetic engineering and biochemical techniques with high resolution spectrometric methodologies and advanced biophysics, including optical and fluorescence spectroscopy, calorimetry, enzyme kinetics studies, bio-layer interferometry, and thermophoresis, contributing to the development of new knowledge and methodologies with applications in biomedical, biotechnological, and pharmacological fields.
The Molecular Biology and Biophysics area is an active member of the CNR Immunology Network (CIN), a strategic initiative aimed at strengthening collaboration among CNR research groups in the field of immunology, enhancing the visibility and impact of research, and promoting the development of international networks.
The Biomolecule Synthesis Area focuses on the design, synthesis, and characterization of small organic molecules, peptides, nucleic acids, peptidomimetics, and bioconjugates, using both solid-phase and solution-phase synthetic methodologies.
Molecules are designed using a range of approaches, from library screening to rational design, aiming to target molecular systems involved in human diseases. In addition to traditional chemical synthesis, protocols for site-specific synthesis and bioconjugation are developed using green chemistry strategies and chemoselective methodologies. The approaches employed include click chemistry, chemical ligation, and reactions assisted by microwave or ultrasound irradiation. Molecular characterization of purified biomolecules is carried out using chromatographic, spectrometric and spectroscopic techniques, as well as advanced biophysical methods.
Thanks to the modern and automated instrumentation available in our synthesis laboratories and within the SIM facility, synthetic processes can be optimized, molecules with high purity can be obtained, and products can be thoroughly characterized. This area represents a strategic platform for the research and development of new molecular systems with applications in the biomedical and biotechnological fields.
The Computational Modelling of Biomolecules Area focuses on the development and application of advanced computational approaches to investigate biomolecular structures, aiming to elucidate their physicochemical properties, dynamic behaviour, and molecular interactions.
The computational approach includes molecular modelling, rational drug design, molecular dynamics (MD) simulations, docking studies, ab initio quantum mechanical (QM) calculations, computational spectroscopy, artificial intelligence–based methods for structure prediction, and statistical analysis of structural databases.
The area also benefits from access to high-performance computing systems (multi-GPU clusters and multi-CPU clusters) and computing resources at CINECA (subject to approval of submitted scientific projects).
The Computational Biomolecular Modelling Area is an active member of the CNR Structural Biology Network (SBN@CNR), a national network dedicated to the development and sharing of skills and infrastructure in the field of structural biology.



The term STEM (an acronym derived from the English initials of the four different disciplines: Science, Technology, Engineering, and Mathematics) indicates the scientific, technological, engineering, and mathematical disciplines that, following the ongoing technological-digital revolution, represent the driving force for the development of the economic, social, and cultural fabric.
Through the involvement of our country's universities and academic institutions, the Ministry intends to disseminate initiatives useful for promoting the development of technical and engineering knowledge and skills among young people. This involvement is now also ensured thanks to the commitment of individual universities in innovative STEM training projects, promoted by the "STEM Università 2024" funding from the Department for Equal Opportunities of the Presidency of the Council of Ministers through a Public Notice aimed at also increasing the support and guidance capabilities of teachers in choosing the study path of female and male students.






Social channels